Belite Bio, Inc
BLTE · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$36 | -$32 | -$13 | -$10 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | -$5 | -$2 | $0 |
| Stock-Based Comp. | $9 | $4 | $1 | $2 |
| Change in WC | $1 | -$2 | -$0 | $1 |
| Other Non-Cash | -$4 | $5 | $2 | -$0 |
| Operating Cash Flow | -$29 | -$30 | -$11 | -$7 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$188 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $78 | $0 | $0 | $0 |
| Other Inv. Act. | -$0 | $0 | $0 | $0 |
| Investing Cash Flow | -$111 | -$0 | -$0 | -$0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $42 | $77 | $38 | -$1 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $41 | -$1 | -$1 | $0 |
| Financing Cash Flow | $84 | $76 | $37 | -$1 |
| Forex Effect | -$0 | $0 | -$0 | -$0 |
| Net Chg. in Cash | -$56 | $46 | $25 | -$8 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $88 | $42 | $17 | $26 |
| End Cash | $32 | $88 | $42 | $17 |
| Free Cash Flow | -$29 | -$30 | -$12 | -$8 |